Consensus Stryker Corporation Mexican S.E.

Stocks

SYK *

US8636671013

Medical Equipment, Supplies & Distribution

End-of-day quote Mexican S.E. 15/09/2026			5-day change	1st Jan Change
4,828.00 ^MXN	+1.22%		+1.22%	-24.56%

18/09	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
18/09	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT

faff9db8a197419940b4685f5e.eZyUxhyvCOnnEwPU1PSwv1UG9fbJjy4J-D9UcEj7pso.TqXOo0TpO7arVUmLo7X-2CZwt6-PzhdnunAMBj2C9YYh36a_WNo5hJ5aOw~8507ac838d0bac5a74e9f37ca7abea7f

Analysts' recommendations: Stryker Corporation

18/09	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
18/09	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
14/09	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
09/09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
09/09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT
09/09	BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating	MT
18/08	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
13/08	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
06/08	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
04/08	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
03/08	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
31/07	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
31/07	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
31/07	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
31/07	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT
31/07	Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating	MT
31/07	BTIG Adjusts Price Target on Stryker to $358 From $371, Maintains Buy Rating	MT
31/07	Piper Sandler Adjusts Price Target on Stryker to $390 From $420, Maintains Overweight Rating	MT
31/07	JPMorgan Adjusts Price Target on Stryker to $350 From $400, Maintains Overweight Rating	MT
31/07	Bernstein Adjusts Price Target on Stryker to $420 From $410, Maintains Outperform Rating	MT
30/07	The Fed Gets a Better Inflation Number
29/07	UBS Upgrades Stryker to Buy From Neutral, Adjusts Price Target to $400 From $380	MT
14/07	Goldman Sachs Adjusts Price Target on Stryker to $339 From $363, Maintains Neutral Rating	MT
13/07	BTIG Research Adjusts Stryker Price Target to $371 From $379, Maintains Buy Rating	MT
10/07	Argus Research Adjusts Stryker Price Target to $370 From $350	MT

More recommendations

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
STRYKER CORPORATION			+36.04%
SMITH & NEPHEW PLC			+23.34%
GLAUKOS CORPORATION			+20.36%
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.			+49.1%
DOUBLE MEDICAL TECHNOLOGY INC.	-	-	+33.88%
INSPIRE MEDICAL SYSTEMS, INC.			-20.47%
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.			+50.13%
Average			+27.48%
Weighted average by Cap.			+33.45%